Advertisement

Cutera, Inc. CUTR

Set alert

Price alert · CUTR

All alert types
0.10 USD 0.00 0.00%

At close · Mar 12

0.09 Day range 0.0969

52-week range unavailable

YTD
0.00%
1 year
0.00%
Open
0.09
Prev close
0.0969
Mkt cap
6.61M
Vol
17.51M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.09
High
0.0969
Forward P/E
-0.10
Beta
1.35
Short ratio
9.16
Inst. own
37.39%
Dividend
0.00
Ex-div date
50-d avg
0.4806
200-d avg
1.25
1y target
2.00

2Y chart

Chart tools
Interval

Events in this range
  • May 9, 2023Earnings: -0.8; estimate -0.3; surprise -166.67%
  • Aug 8, 2023Earnings: -0.69; estimate -0.55; surprise -25.45%
  • Mar 21, 2024Earnings: -1.36; estimate -0.91; surprise -49.45%
  • Mar 22, 2024Rating: William Blair · Underperform → Market Perform
  • Mar 22, 2024Rating: Stephens & Co. · Overweight → Overweight
  • May 9, 2024Earnings: -1.02; estimate -1.09; surprise 6.42%
  • Jun 21, 2024Rating: Piper Sandler · Neutral → Neutral
  • Jun 25, 2024Rating: Stephens & Co. · Overweight → Overweight
  • Aug 8, 2024Earnings: -1.2; estimate -0.9; surprise -33.33%
  • Aug 9, 2024Rating: Piper Sandler · Neutral → Neutral
  • Aug 9, 2024Rating: Stephens & Co. · Overweight → Overweight
  • Nov 7, 2024Earnings: -1.85; estimate -0.96; surprise -92.71%
Signals (68)
NameDateAgo
MACD: Buy SignalMar 26, 20251 year ago
RSI: OversoldMar 5, 20251 year ago
SMA: BearishFeb 25, 20251 year ago
MACD: Sell SignalFeb 24, 20251 year ago
MACD: Buy SignalFeb 18, 20251 year ago
SMA: BullishFeb 13, 20251 year ago
SMA: BearishFeb 11, 20251 year ago
MACD: Sell SignalFeb 10, 20251 year ago
MACD: Buy SignalFeb 5, 20251 year ago
MACD: Sell SignalJan 28, 20251 year ago
SMA: BullishJan 15, 20251 year ago
SMA: BearishJan 13, 20251 year ago
RSI: OverboughtJan 6, 20251 year ago
SMA: BullishJan 3, 20251 year ago
MACD: Buy SignalNov 26, 20241 year ago
RSI: OversoldNov 8, 20241 year ago
MACD: Sell SignalOct 23, 20242 years ago
MACD: Buy SignalOct 18, 20242 years ago
MACD: Sell SignalOct 17, 20242 years ago
MACD: Buy SignalAug 21, 20242 years ago
RSI: OversoldAug 9, 20242 years ago
MACD: Sell SignalAug 1, 20242 years ago
MACD: Buy SignalJul 9, 20242 years ago
RSI: OversoldJul 3, 20242 years ago
RSI: OversoldJun 24, 20242 years ago
SMA: BearishJun 5, 20242 years ago
SMA: BullishMay 29, 20242 years ago
SMA: BearishMay 28, 20242 years ago
MACD: Sell SignalMay 10, 20242 years ago
SMA: BullishApr 26, 20242 years ago
SMA: BearishApr 24, 20242 years ago
SMA: BullishApr 23, 20242 years ago
SMA: BearishApr 19, 20242 years ago
SMA: BullishApr 17, 20242 years ago
SMA: BearishApr 16, 20242 years ago
SMA: BullishApr 12, 20242 years ago
MACD: Buy SignalApr 5, 20242 years ago
MACD: Sell SignalMar 25, 20242 years ago
MACD: Buy SignalMar 20, 20242 years ago
MACD: Sell SignalFeb 23, 20242 years ago
SMA: BearishFeb 13, 20242 years ago
SMA: BullishFeb 12, 20242 years ago
MACD: Buy SignalFeb 12, 20242 years ago
SMA: BearishJan 30, 20242 years ago
SMA: BullishJan 26, 20242 years ago
SMA: BearishJan 23, 20242 years ago
MACD: Sell SignalJan 18, 20242 years ago
RSI: OverboughtJan 9, 20242 years ago
SMA: BullishDec 21, 20232 years ago
RSI: OversoldNov 9, 20232 years ago
RSI: OversoldOct 26, 20233 years ago
MACD: Buy SignalOct 16, 20233 years ago
MACD: Sell SignalOct 12, 20233 years ago
MACD: Buy SignalOct 11, 20233 years ago
MACD: Sell SignalSep 21, 20233 years ago
RSI: OversoldSep 21, 20233 years ago
MACD: Buy SignalSep 1, 20233 years ago
RSI: OversoldAug 24, 20233 years ago
SMA: BearishAug 9, 20233 years ago
MACD: Sell SignalAug 9, 20233 years ago
SMA: BullishJul 27, 20233 years ago
SMA: BearishJul 24, 20233 years ago
SMA: BullishJul 21, 20233 years ago
MACD: Buy SignalJul 11, 20233 years ago
MACD: Sell SignalJul 5, 20233 years ago
MACD: Buy SignalJul 3, 20233 years ago
MACD: Sell SignalJun 23, 20233 years ago
RSI: OversoldMay 11, 20233 years ago

Key statistics

Market cap
6.61M
Enterprise value
381.92M
Trailing P/E
0.00
Forward P/E
-0.10
PEG ratio
0.00
Price / sales
0.04
Price / book
0.00
EPS (TTM)
-7.18
Beta
1.35
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-92.59%
Revenue (TTM)
155.21M
Revenue growth
-30.10%
Free cash flow
-79.45M
Total cash
57.61M
Total debt
432.20M
Return on equity
0.00%
Shares outstanding
20.19M
Short % of float
21.90%
50-day average
0.4806
200-day average
1.25

Analyst view

Consensus: buy

Buy
Price target (mean) 2.00
Ratings (0m) 3 1 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.98.

Earnings history

Financials — quick view

All financials
CUTR Revenue — quarterly 32.50M
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 2024
CUTR Net income — quarterly -39.02M
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 2024
CUTR EPS — quarterly -1.94
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 2024

Earnings

CUTR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.96-1.85-0.89-92.71%
Aug 8, 2024Jun 1, 2024-0.90-1.20-0.30-33.33%
May 9, 2024Mar 1, 2024-1.09-1.02+0.07+6.42%
Mar 21, 2024Dec 1, 2023-0.91-1.36-0.45-49.45%
Aug 8, 2023Jun 1, 2023-0.55-0.69-0.14-25.45%
May 9, 2023Mar 1, 2023-0.30-0.80-0.50-166.67%

Upgrades / downgrades

CUTR analyst upgrades and downgrades
DateFirmActionFromTo
Aug 9, 2024Stephens & Co.mainOverweightOverweight
Aug 9, 2024Piper SandlerreitNeutralNeutral
Jun 25, 2024Stephens & Co.reitOverweightOverweight
Jun 21, 2024Piper SandlermainNeutralNeutral
Mar 22, 2024Stephens & Co.reitOverweightOverweight
Mar 22, 2024William BlairupUnderperformMarket Perform

About Cutera, Inc.

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
cutera.com

News

Your note

Sign in to keep a note on CUTR — it syncs with the Stock Master app.

Insider holders

CUTR insider holders
InsiderRelationLatest transactionDateShares held
DRUMMOND STUARTChief Financial OfficerPurchaseAug 28, 202319,678
HARRIS TAYLOR CChief Executive OfficerPurchaseAug 28, 2023279,336
HOPKINS SHEILA AChief Executive OfficerStock Award(Grant)Jul 31, 202341,219
JONES JEFFREY S.Chief Operating OfficerStock Award(Grant)Aug 27, 202312,306
KARAVITIS MICHAELChief Technology OfficerSaleMay 15, 20240
MOWRY DAVID HDirectorStock Award(Grant)May 10, 2023170,900

Institution ownership

CUTR institution ownership
Holder% heldSharesValueReported
Pura Vida Investments, Llc5.77%1,165,497381.47KSep 29, 2024
Vanguard Group Inc4.53%914,629299.36KSep 29, 2024
Millennium Management Llc3.79%764,162250.11KSep 29, 2024
Hawk Ridge Capital Management, LP2.20%444,909145.62KSep 29, 2024
Gamco Investors Inc1.74%351,600115.08KSep 29, 2024
Boothbay Fund Management, LLC1.62%326,770106.95KSep 29, 2024

Fund ownership

CUTR fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.94%594,164194.47KSep 29, 2024
EQ Advisors Trust-1290 VT Gamco Small Company Value Port1.58%319,000104.41KSep 29, 2024
Vanguard Extended Market Index Fund1.26%255,22483.53KSep 29, 2024
Gabelli Small Cap Growth Fund1.12%226,00073.97KSep 29, 2024
Federated Hermes MDT Mid Cap Growth Fund0.63%127,04141.58KJul 30, 2024
Fidelity Extended Market Index Fund0.56%113,25437.07KOct 30, 2024
Advertisement